X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (229) 229
Journal Article (210) 210
Publication (22) 22
Conference Proceeding (12) 12
Newspaper Article (9) 9
Book / eBook (2) 2
Book Chapter (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (225) 225
hygiene (225) 225
medical or veterinary science (225) 225
preparations for medical, dental, or toilet purposes (225) 225
chemistry (168) 168
metallurgy (166) 166
organic chemistry (128) 128
specific therapeutic activity of chemical compounds ormedicinal preparations (128) 128
peptides (114) 114
heterocyclic compounds (84) 84
humans (79) 79
investigating or analysing materials by determining theirchemical or physical properties (75) 75
measuring (75) 75
physics (75) 75
testing (75) 75
index medicus (71) 71
biochemistry (62) 62
enzymology (62) 62
beer (61) 61
microbiology (61) 61
mutation or genetic engineering (61) 61
spirits (61) 61
vinegar (61) 61
wine (61) 61
animals (58) 58
compositions or test papers therefor (56) 56
condition-responsive control in microbiological orenzymological processes (56) 56
measuring or testing processes involving enzymes, nucleicacids or microorganisms (56) 56
processes of preparing such compositions (56) 56
mice (50) 50
female (40) 40
cell line, tumor (35) 35
cancer (34) 34
oncology (33) 33
antineoplastic agents - pharmacology (25) 25
male (22) 22
mice, nude (20) 20
chemistry, medicinal (19) 19
xenograft model antitumor assays (18) 18
structure-activity relationship (17) 17
pathway (15) 15
phosphatidylinositol 3-kinases - antagonists & inhibitors (15) 15
cell biology (14) 14
expression (14) 14
mutation (14) 14
antineoplastic agents - therapeutic use (13) 13
discovery (13) 13
phosphatidylinositol 3-kinases - metabolism (13) 13
pyrimidines - pharmacology (13) 13
article (12) 12
compositions thereof (12) 12
culture media (12) 12
microorganisms or enzymes (12) 12
middle aged (12) 12
models, molecular (12) 12
phase-i (12) 12
potent (12) 12
propagating, preserving or maintaining microorganisms (12) 12
antineoplastic agents - chemistry (11) 11
metabolism (11) 11
neoplasms - drug therapy (11) 11
nicotinamide phosphoribosyltransferase - antagonists & inhibitors (11) 11
phosphorylation (11) 11
sulfonamides - pharmacology (11) 11
tumors (11) 11
biochemistry & molecular biology (10) 10
health aspects (10) 10
protein kinase inhibitors - pharmacology (10) 10
adult (9) 9
apoptosis (9) 9
cell proliferation - drug effects (9) 9
cell survival - drug effects (9) 9
chemistry, organic (9) 9
enzyme inhibitors - chemistry (9) 9
identification (9) 9
mutations (9) 9
nicotinamide phosphoribosyltransferase - metabolism (9) 9
rats (9) 9
aged (8) 8
agriculture (8) 8
animal husbandry (8) 8
breast cancer (8) 8
care of birds, fishes, insects (8) 8
drug synergism (8) 8
fishing (8) 8
forestry (8) 8
hunting (8) 8
molecular structure (8) 8
neoplasm transplantation (8) 8
new breeds of animals (8) 8
pyrimidines - chemistry (8) 8
rearing or breeding animals, not otherwise provided for (8) 8
trapping (8) 8
administration, oral (7) 7
antitumor-activity (7) 7
breast neoplasms - drug therapy (7) 7
bridged bicyclo compounds, heterocyclic - pharmacology (7) 7
cells (7) 7
crystallography, x-ray (7) 7
disease models, animal (7) 7
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (438) 438
French (71) 71
German (31) 31
Spanish (20) 20
Chinese (16) 16
Korean (15) 15
Portuguese (11) 11
Japanese (3) 3
Polish (3) 3
Turkish (3) 3
Lithuanian (2) 2
Serbian (2) 2
Slovenian (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The EMBO Journal, ISSN 0261-4189, 08/2012, Volume 31, Issue 17, pp. 3513 - 3523
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2013, Volume 19, Issue 2, pp. 202 - 208
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2017, Volume 23, Issue 18, pp. 5561 - 5572
Purpose: Triple-negative breast cancer (TNBC) is a heterogeneous subgroup of breast cancer that is associated with a poor prognosis. We evaluated the activity... 
INACTIVATION | PALBOCICLIB | ACTIVATION | CYCLIN-E | ONCOLOGY | PHOSPHORYLATION | SUBTYPES | PROLIFERATION-QUIESCENCE DECISION | RESISTANCE | LETROZOLE | ASSOCIATION | Cyclin-Dependent Kinase 6 - antagonists & inhibitors | Humans | Receptors, Androgen - metabolism | Molecular Imaging | Phosphatidylinositol 3-Kinases - metabolism | Triple Negative Breast Neoplasms - drug therapy | Time-Lapse Imaging | Triple Negative Breast Neoplasms - pathology | Female | Antineoplastic Agents - pharmacology | Cyclin-Dependent Kinase 4 - antagonists & inhibitors | Single-Cell Analysis | Disease Models, Animal | Cell Survival - drug effects | Piperazines - pharmacology | Phenotype | Animals | Mitosis - drug effects | Receptors, Androgen - genetics | Triple Negative Breast Neoplasms - genetics | Signal Transduction - drug effects | Triple Negative Breast Neoplasms - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Pyridines - pharmacology | Drug Resistance, Neoplasm - drug effects | Biotechnology | Deregulation | Reentry | Mitosis | Fluorescence | Breast cancer | Cyclin-dependent kinase 4 | Subgroups | 1-Phosphatidylinositol 3-kinase | Cyclin-dependent kinase 2 | Sensitivity | Inhibitors | Experimental design | Cell lines | Xenografts | Breast | Inhibition | Cancer
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2015, Volume 112, Issue 32, pp. E4410 - E4417
Journal Article
AIP Conference Proceedings, ISSN 0094-243X, 11/2018, Volume 2039, Issue 1
61754 MLD of waste water is generated in India from various sources and about 38791 MLD (62%) of waste water remains untreated and is directly discharged into... 
Batch Study | Adsorbents | Economic treatment process | Heavy metal | Waste water | Dust | Carbon content | Low cost | Chromium | Electroplating | Wastewater treatment | Heavy metals
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 24, pp. 2330 - 2341
Journal Article